info@buecher-doppler.ch
056 222 53 47
Warenkorb
Ihr Warenkorb ist leer.
Gesamt
0,00 CHF
  • Start
  • Mergers and Acquisitions in the Global Pharmaceutical Industry

Mergers and Acquisitions in the Global Pharmaceutical Industry

Angebote / Angebote:

Project Report from the year 2006 in the subject Communications - Public Relations, Advertising, Marketing, Social Media, grade: 65 % - B, University of Sunderland, course: Global Corporate Strategy, language: English, abstract: Mergers and acquisitions are of major importance in the pharmaceutical industry. In order to evaluate the dynamics of this particular industry, this paper critically evaluates the pre- and post- merger situation of GlaxoSmithKline concerning its ready-access to markets, know-how and management capability. Furthermore, strengths and weaknesses and merger's outcomes will be outlined. Critical push and pull factors affecting M&A, activity in North America will be analysed, using Pfizer and Pharmacia as an example. In addition, general reasons for M&A, failure in the pharmaceutical industry will be illustrated focussing on the M&A, activity of GlaxoSmithKline. Finally, using two global pharmaceutical players (GSK and Astrazeneca), the merits and demerits of the McKinsey's five step programme will be discussed.
Folgt in ca. 10 Arbeitstagen

Preis

24,90 CHF